StonvexLoading…
StonvexStonvexStonvexCore line items from AN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-23 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $7.22B | $6.55B | $27.63B | $20.70B | $13.66B |
Operating Income | Not available | $314.30M | $1.24B | $926.00M | $553.60M |
Net Income | Not available | $205.40M | $649.10M | $477.00M | $86.40M |
EPS (Diluted) | $5.58 | $5.85 | $17.04 | $12.36 | $6.73 |
Total Assets | Not available | $14.62B | $14.39B | $14.20B | $13.57B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $65.50M | $58.60M | $97.60M | $62.90M |
Free Cash Flow OCF − CapEx | Not available | $-34.20M | $-197.50M | $-261.70M | $-384.50M |
Shares Outstanding | Not available | 33.90M | 35.20M | 36.90M | 37.70M |